Skip to main content
Targeting Ras in myeloid leukemias.
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group.
Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors.
Testing of new agents in childhood cancer preclinical models: meeting summary.
Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter.